Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRoisin Eilish O'Cearbhaill, Daneng Li, Howard T. Thaler, Paul J. Sabbatini, Jason A. Konner, Martee Leigh Hensley, Carol A Aghajanian, Stuart M. Lichtman, William P. Tew
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy
10.1016/s1040-8428(00)00088-3 · 2001
Cancer statistics, 2010
10.3322/caac.20073 · 2010
Ovarian cancer. Survival and treatment differences by age
10.1002/cncr.2820710206 · 1993
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience
10.1002/cncr.2820710218 · 1993
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study
10.1200/jco.2006.10.2517 · 2007
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973–87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina
10.1002/ssu.2980100107 · 1994
Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience
10.1002/cncr.2820710223 · 1993
An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study
10.1016/j.ygyno.2004.05.033 · 2004
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Treatment patterns by decade of life in elderly women (> or =70years of age) with ovarian cancer
10.1016/j.ygyno.2005.04.037 · 2005
Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study
10.1200/jco.20.1.173 · 2002
Treatment of ovarian cancer in elderly women. Mayo Clinic-North Central Cancer Treatment Group studies
10.1002/cncr.2820710219 · 1993
Age does not influence taxol dose intensity in recurrent carcinoma of the ovary
10.1002/cncr.2820710216 · 1993
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum–taxane chemotherapy
10.1016/j.ygyno.2007.04.012 · 2007
The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer
10.1016/j.ygyno.2010.08.026 · 2010
Ovarian cancer in the elderly
10.1016/s1040-8428(03)00100-8 · 2004
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Mullerian tumors
10.1016/j.ygyno.2008.10.015 · 2009
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study
10.1200/jco.20.2.494 · 2002
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
10.1056/nejmoa052985 · 2006
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
10.1056/nejm199612263352603 · 1996
10.1200/jco.2001.19.4.1001
10.1200/jco.2001.19.4.1001 · 2001
Toxicities of modified outpatient regimen of IV/Ip Paclitaxel and Ip Cisplatin in women with newly diagnosed ovarian cancer: 0123
10.1136/ijgc-00009577-200610001-00122 · 2006
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
10.1016/s1053-4296(03)00031-6 · 2003
Do elderly cancer patients care about cure? Attitudes to radical gynecologic oncology surgery in the elderly
10.1006/gyno.2001.6178 · 2001
Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer
10.1006/gyno.2002.6759 · 2002
Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer
10.2165/00002512-200522090-00007 · 2005
Greater risks of chemotherapy toxicity in elderly patients with cancer
2003
Management of cancer in the older person: a practical approach
10.1634/theoncologist.5-3-224 · 2000
Predicting chemotherapy toxicity in older adults with cancer: a prospective 500 patient multicenter study
10.1200/jco.2010.28.15_suppl.9001 · 2010
A brief clinical instrument to classify frailty in elderly people
10.1016/s0140-6736(98)04402-x · 1999
Comorbidity and functional status are independent in older cancer patients
10.1200/jco.1998.16.4.1582 · 1998
No additional external references are available.